I was discharged from the hospital 13 days ago and started on the oral anticoagulant Eliquis (apixaban). How much should my clot burden have improved by now?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Expected Clot Burden Improvement After 13 Days on Eliquis

After 13 days on Eliquis (apixaban), you should expect some clot burden reduction, but complete resolution is unlikely—most clots take weeks to months to fully resolve, though therapeutic anticoagulation prevents clot extension and new clot formation within days.

Understanding What Anticoagulation Does

Eliquis doesn't actively "dissolve" clots—your body does that naturally through a process called fibrinolysis. What Eliquis does is:

  • Prevents clot extension (stops the clot from getting bigger) - this happens within hours to days of starting therapeutic anticoagulation
  • Prevents new clots from forming - also effective within the first few days
  • Allows your body's natural clot-dissolving mechanisms to work without new clot formation competing against this process

Timeline for Clot Resolution

Based on the available evidence and clinical experience:

First 1-2 Weeks (Where You Are Now):

  • Clot stabilization has occurred
  • Prevention of clot extension is established
  • Early fibrinolysis (clot breakdown) has begun
  • Minimal to modest reduction in clot size is typical at this stage

Weeks 2-6:

  • Progressive clot resolution continues
  • Most significant reduction in clot burden occurs during this period
  • Symptoms typically improve substantially

Months 3-6:

  • Continued gradual resolution
  • Some residual clot may persist even after 6 months in many patients
  • The goal is preventing recurrence, not necessarily complete clot disappearance

Evidence for Rapid Resolution

One case report showed remarkably fast resolution of left ventricular thrombi with apixaban—gradual resolution starting at day 3 with complete disappearance after one week 1. However, this is exceptional and not typical. This case involved cardiac thrombi, which may behave differently than venous clots.

What Matters Most Clinically

The 2026 AHA/ACC guidelines emphasize that preventing recurrent VTE is the primary goal 2. Eliquis has been proven highly effective for this:

  • In the AMPLIFY study, apixaban showed superior safety with major bleeding occurring in only 0.6% of patients compared to 1.8% with warfarin 3
  • Recurrent VTE rates were low and comparable to traditional therapy 4, 5
  • The drug reaches therapeutic levels rapidly, providing protection within hours of the first dose

Important Caveats

Do not expect imaging to show dramatic improvement at 13 days. If you were to get repeat imaging now:

  • The clot would likely still be visible
  • It may appear only slightly smaller
  • This does NOT mean the treatment isn't working

What indicates successful treatment at this stage:

  • No new symptoms of clot extension (worsening pain, swelling, shortness of breath)
  • Gradual improvement in your symptoms
  • No signs of new clots elsewhere

Duration of Treatment

According to current guidelines, you'll typically need to continue Eliquis for at least 3-6 months for an initial VTE 2. The decision to continue beyond 6 months depends on:

  • Whether your clot was provoked (had a clear trigger) or unprovoked
  • Your bleeding risk
  • Presence of ongoing risk factors

Continue taking Eliquis exactly as prescribed—the most critical period for preventing recurrent clots is actually the first 3 months after diagnosis.

Related Questions

A patient with an acute proximal deep‑vein thrombosis in the superficial femoral vein, prescribed Eliquis (apixaban) 2.5 mg twice daily but likely non‑adherent and wanting discharge, what is the best anticoagulation treatment plan?
What is the appropriate apixaban (Eliquis) dosing regimen for treating pulmonary embolism, including adjustments for renal function, age, weight, and hepatic impairment?
What are the next steps for a patient with deep vein thrombosis (DVT) and unilateral leg swelling, status post (s/p) surgery, who has been placed on Eliquis (apixaban)?
In a patient with a history of two thrombo‑embolic events and a possible hereditary protein C deficiency who is currently on lifelong apixaban (Eliquis) 5 mg twice daily, and whose labs show low protein C, elevated factor VIII, hyperhomocysteinemia, and borderline anticardiolipin IgG, should the anticoagulation regimen be adjusted?
How should a 78-year-old man with prior deep vein thrombosis six months ago, who completed a three-month course of apixaban (Eliquis) and now presents with three-day left lower extremity swelling and occasional pain without redness or warmth, be managed?
How should I explain to a patient that imaging shows quadriceps tendon enthesopathy at the superior patellar pole and a small left calcaneal enthesophyte, with no fracture?
What is the recommended acyclovir dosage for neonates and pediatric patients with chickenpox?
What management should be prescribed for a patient with knee and heel pain involving the quadriceps tendon and Achilles insertion?
What is the appropriate evaluation and management for dysphonia?
What is the recommended management for a ruptured intracranial dermoid cyst that has spilled into the cerebrospinal fluid?
Can you design a one-page A4 plan for the patient that explains eccentric calf‑Achilles exercises?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.